Subject With Chronic Coccygodynia clinical trials

Explore recruiting subject with chronic coccygodynia clinical trials.

Also recruiting in Europe

Subject With Chronic Coccygodynia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 3 confirmatory, randomised 1:1 double-blind, placebo-controlled study evaluating the analgesic efficacy of capsaicin 8% patches in chronic coccygodynia. CAPSACOX Study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Subject With Chronic Coccygodynia trials by city

Subject With Chronic Coccygodynia in Toronto Subject With Chronic Coccygodynia in Vancouver Subject With Chronic Coccygodynia in Montreal Subject With Chronic Coccygodynia in Calgary Subject With Chronic Coccygodynia in Edmonton Subject With Chronic Coccygodynia in Ottawa Subject With Chronic Coccygodynia in Winnipeg Subject With Chronic Coccygodynia in Quebec City Subject With Chronic Coccygodynia in Hamilton Subject With Chronic Coccygodynia in Kitchener Subject With Chronic Coccygodynia in London Subject With Chronic Coccygodynia in Halifax Subject With Chronic Coccygodynia in New York Subject With Chronic Coccygodynia in Los Angeles Subject With Chronic Coccygodynia in Chicago Subject With Chronic Coccygodynia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease